Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Steroids. 2013 Nov 16;81:88–98. doi: 10.1016/j.steroids.2013.10.018

Figure 5. E2 replacement suppressed body fat accumulation and increases blood triglycerides levels.

Figure 5

A. Average percent change in body fat/body weight during the 4 weeks averaged for each group. WT (black bars), KIKO (dark gray bars) and ERKO (light gray bars) in intact and oil-treated and E2-treated ovariectomized females. Data was analyzed by a one-way ANOVA (WT: p<0.001, df=2, F=13.6; KIKO: p<0.01, df=2, F=7.26; ERKO: p<0.05, df=2, F=4.26) with Bonferroni-Dunn multiple comparison tests across and within genotypes (** p<0.01, *** p<0.001). B. The average percent change in lean mass/body weight averaged for each group. Data was analyzed by a one-way ANOVA (E2: p<0.05, df=2; F=3.65; oil: p<0.01, df=2, F=7.65; oil: ns) with Bonferroni-Dunn multiple comparison tests across and within genotypes (* p<0.05; ** p<0.01). C. Blood triglycerides levels (mg/dl) averaged for each group. Data was analyzed by a one-way ANOVA with Bonferroni-Dunn multiple comparison tests across and within genotypes (* p<0.05). D. Blood glucose levels (mg/dl) averaged for each group. Data was analyzed by a one-way ANOVA with Bonferroni-Dunn multiple comparison tests across and within genotypes.